Peptide-Bound Aflibercept Eye Drops for Treatment of Neovascular Age-Related Macular Degeneration in Nonhuman Primates.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Peptide-Bound Aflibercept Eye Drops for Treatment of Neovascular Age-Related Macular Degeneration in Nonhuman Primates.
- Published In:
- Advanced science (Weinheim, Baden-Wurttemberg, Germany), 12(11), e2410744 (2025)
- Authors:
- Fan, Xingyan, Jiang, Kuan, Zhao, Yongqian, Lee, Benjamin Tk, Geng, Feiyang, Brelen, Marten E, Lu, Weiyue, Wei, Gang
- Database ID:
- RPEP-10894
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10894APA
Fan, Xingyan; Jiang, Kuan; Zhao, Yongqian; Lee, Benjamin Tk; Geng, Feiyang; Brelen, Marten E; Lu, Weiyue; Wei, Gang. (2025). Peptide-Bound Aflibercept Eye Drops for Treatment of Neovascular Age-Related Macular Degeneration in Nonhuman Primates.. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 12(11), e2410744. https://doi.org/10.1002/advs.202410744
MLA
Fan, Xingyan, et al. "Peptide-Bound Aflibercept Eye Drops for Treatment of Neovascular Age-Related Macular Degeneration in Nonhuman Primates.." Advanced science (Weinheim, 2025. https://doi.org/10.1002/advs.202410744
RethinkPeptides
RethinkPeptides Research Database. "Peptide-Bound Aflibercept Eye Drops for Treatment of Neovasc..." RPEP-10894. Retrieved from https://rethinkpeptides.com/research/fan-2025-peptidebound-aflibercept-eye-drops
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.